Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
MAP Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Sell | $46.1K | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Sell | $9.8K | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
AUXILIUM PHARMACEUTICALS INCListing unverified | Sell | $24M | SEC |